NCT05958199 2025-06-27A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NextPoint Therapeutics, Inc.Phase 1 Suspended131 enrolled
NCT01337518 2012-12-18A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerEnzon Pharmaceuticals, Inc.Phase 1 Suspended150 enrolled
NCT00065572 2011-01-26Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)AstraZenecaPhase 2 Suspended